Vardhman Pharma Distributors Profile
Key Indicators
- Authorised Capital ₹ 3.10 Cr
as on 05-07-2024
- Paid Up Capital ₹ 3.02 Cr
as on 05-07-2024
- Company Age 32 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 203.36 Cr
as on 05-07-2024
- Revenue 16.37%
(FY 2023)
- Profit 37.61%
(FY 2023)
- Ebitda 1.31%
(FY 2023)
- Net Worth 22.62%
(FY 2023)
- Total Assets -46.33%
(FY 2023)
About Vardhman Pharma Distributors
- CIN/LLPIN
U85110TG1992PTC168466
- Company No.
013757
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Dec 1992
- Date of AGM
28 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vardhman Pharma Distributors?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahendra Chowhan  | Managing Director | 15-May-1998 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Usha Chowhan | Director | 17-May-2004 | Current |
| Premkumar Karra | Nominee Director | 26-Nov-2009 | Current |
| Arvind Venkat | Nominee Director | 23-Oct-2008 | Current |
Financial Performance of Vardhman Pharma Distributors.
Vardhman Pharma Distributors Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.37% increase. The company also saw a substantial improvement in profitability, with a 37.61% increase in profit. The company's net worth Soared by an impressive increase of 22.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vardhman Pharma Distributors?
In 2023, Vardhman Pharma Distributors had a promoter holding of 100.00%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Focus Medisales Private LimitedActive 25 years 9 monthsMahendra Chowhan and Usha Chowhan are mutual person
Vardhman Medisales Private LimitedActive 2 years 9 monthsMahendra Chowhan and Usha Chowhan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 16 Jun 2022 | ₹45.00 Cr | Satisfied |
Others Creation Date: 30 Aug 2021 | ₹5.00 Cr | Satisfied |
Others Creation Date: 27 May 2021 | ₹0.08 M | Satisfied |
How Many Employees Work at Vardhman Pharma Distributors?
Vardhman Pharma Distributors has a workforce of 423 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vardhman Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vardhman Pharma Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
